Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes
ExPrEs
Rehabilitation, NMES and High Protein to Reduce Post ICU Syndrome in the Elderly
1 other identifier
interventional
60
1 country
1
Brief Summary
Elderly patients who experience a prolonged ICU stay are at high risk for developing post intensive care unit syndrome (PICS), a serious medical condition manifested by loss of muscle mass, weakness, malnutrition and neurocognitive decline. PICS often leads to chronic disability, prolonged mechanical ventilation and the need for costly extended stays in long term care facilities (LTCs). The investigators' preliminary study shows attempts at rehabilitating patients who have already developed PICS are minimally effective, resulting in only modest improvements in functionality. This project will determine the effects of mobility-based physical rehabilitation (MPR) combined with neuromuscular electric stimulation (NMES) and high protein supplementation (HPRO) early in a patients ICU stay on preventing PICS related musculoskeletal and functional deficits, and improving clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 21, 2015
CompletedFirst Posted
Study publicly available on registry
July 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJuly 3, 2025
March 1, 2025
11 years
July 21, 2015
June 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Muscle mass
Muscle mass as measured by lower extremity muscle volume
14 days
Global body strength
Muscle group strength as measured by hand held dynamometer and by hand grip strength
14 days
Mobility status
Outcome as measured by combined 6 minute walk distance and gait speed
14 days
Short Physical Performance Battery
Short Physical Performance battery will be assessed at baseline and at 7 and 14 days.
14 days
Secondary Outcomes (4)
Time to weaning
14 days
ICU/Hospital length of stay
14 days
Discharge disposition
30 days
Weaning success
14 days
Study Arms (2)
Mobility-based Physical Rehab (MPR)
NO INTERVENTIONICU control group receiving only mobility based rehabilitation (MPR).
MPR and Neuromuscular Stimulation and HPRO
ACTIVE COMPARATORICU group receiving mobility based rehabilitation and NMES and High protein supplementation.
Interventions
The MPR provides strength and cardiopulmonary endurance training, which consist of exercises to promote function movements. Intensity is based on patient's hemodynamic responses and subjective report using Modified Borg Dyspnea Scale. Intensity, duration, or type of activity will be modified each session to achieve a moderately intense physiologic response. The NMES protocol requires self-adhesive surface electrodes be placed on quadriceps muscles and lower leg bilaterally, twice daily. This protocol is based on prior NMES protocols used to stimulate muscle protein synthesis in older diabetic patients, preserve muscle mass in intensive care patients and increase strength in older adults after knee replacement. The HPRO intervention is based on caloric needs, calculated using validated equations to maintain positive nitrogen balance. Protein will be supplemented as isolated amino acids twice/day to deliver \~15g of essential amino acids per serving, with a goal of 1.6 g/kg/day.
Eligibility Criteria
You may qualify if:
- Age ≥ 45 years
- Respiratory insufficiency requiring mechanical ventilation (MV)
- ICU presentation \< 6 days
- Patient or legally authorized representative able to provide written or witnessed verbal informed consent in English
- All four limbs intact and mobile
- Eligible for and able to participate in physical therapy
- Pre admission Barthel Index \>70
You may not qualify if:
- Acute kidney injury with a glomerular filtration rate \< 30 ml/min
- Diagnosis of severe organ dysfunction including end stage liver disease or cirrhosis
- Diagnosis of active cancer
- Acute or chronic organ transplant rejection
- Exceedingly high mechanical ventilator settings (FiO2\>60%, PEEP\>12) or alternative modes of mechanical ventilation (inverse ratio pressure control, airway pressure release ventilation)
- Severe functional impairment or physical impairment to rehabilitation
- On high dose vasopressor agents (\> 5mcg of norepinephrine or equivalent)
- Liver function tests \> 2.5 x normal limits (normal reference ranges include AST between 10 and 40 units/L or ALT between 7 and 56 units/L)
- Chronic dementia or cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U of Maryland, Baltimore, Professional Schools IRB
Baltimore, Maryland, 21201, United States
Related Publications (1)
Verceles AC, Serra M, Davis D, Alon G, Wells CL, Parker E, Sorkin J, Bhatti W, Terrin ML. Combining exercise, protein supplementation and electric stimulation to mitigate muscle wasting and improve outcomes for survivors of critical illness-The ExPrES study. Heart Lung. 2023 Mar-Apr;58:229-235. doi: 10.1016/j.hrtlng.2022.11.013. Epub 2022 Dec 5.
PMID: 36473808DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 21, 2015
First Posted
July 28, 2015
Study Start
May 1, 2015
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
July 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share